Other Names c-Jun N- terminal kinase kinase 1; C-JUN N-terminal kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 4; EC 2.7.12.2; JNK activating kinase 1; JNK kinase 1; JNKK; JNKK 1; JNKK1; kinase SEK1; MAP kinase kinase 4; MAP2K4; MAPK/ERK kinase 4; MAPKK 4; MKK4; MP2K4; PRKMK4; SAPK/ERK kinase 1; SEK1; SERK1
All Sites Human: Thr261; Mouse: Thr259; Rat: Thr259
Storage/Stability Store at -20℃/1 year
Form Or Antibody
Form of Antibody Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Immunogen The antiserum was produced against synthesized phosphopeptide derived from human SEK1/MKK4 around the phosphorylation site of threonine261 (A-K-TP-R-D).
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Specificty Sensitivity
Specificity/Sensitivity SEK1/MKK4 (Phospho-Thr261) antibody detects endogenous levels of SEK1/MKK4 only when phosphorylated at threonine 261.
ReferencesLin A., Science 268:286-290(1995).
Derijard B., Science 267:682-685(1995).
Su G.H., Cancer Res. 58:2339-2342(1998).